Aptevo Therapeutics Inc. [APVO] - equity issuance
Aptevo Therapeutics Inc. is issuing shares at a purchase price of $4.03 per share, along with warrants to purchase up to 4,308,540 shares at the same exercise price, with a registration statement to be filed by August 22, 2026.
Why this matters
Aptevo Therapeutics Inc., a Delaware-incorporated company in the pharmaceutical preparations industry, focuses on developing novel immunotherapy treatments for cancer and other life-threatening diseases. The company has announced an equity issuance involving the sale of shares at $4.03 per share, alongside warrants to purchase up to 4,308,540 shares at the same exercise price. This action is part of a private placement transaction, with net proceeds intended for working capital purposes. Additionally, Aptevo has entered into warrant inducement agreements with certain holders of existing common warrants, who have agreed to exercise their warrants for cash at a reduced price of $4.03 per share. The company plans to file a registration statement by August 22, 2026, covering the resale of these shares and warrants.